Literature DB >> 10845935

Hepatocyte growth factor-stimulated invasiveness of monocytes.

M Beilmann1, G F Vande Woude, H P Dienes, P Schirmacher.   

Abstract

Hepatocyte growth factor (HGF) is a pluripotent cytokine with mitogenic, motogenic, and morphogenic activity for mainly epithelial and endothelial target cells. We previously demonstrated that the specific HGF receptor, MET, is induced in stimulated peripheral blood monocytes. In this study, we analyzed the functional consequences of MET activation in primary cultures of peripheral blood monocytes from healthy donors. After stimulation of MET-expressing monocytes with recombinant HGF, the gene-expression profile of peripheral blood mononuclear cells and monocytes was significantly modulated, especially with regard to genes involved in cell movement. After stimulation of primary cultured monocytes with HGF, invasion assays showed a significantly increased matrigel invasion rate that was completely abolished by neutralizing antibodies to HGF. The HGF-activated invasiveness and the altered gene-expression profile suggest a proinflammatory role for HGF stimulation of monocytes and support the hypothesis that the HGF/MET signaling system plays an important part in the activation of the nonspecific cellular inflammatory response. (Blood. 2000;95:3964-3969)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10845935

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

1.  Differential monocyte responses to TLR ligands in children with autism spectrum disorders.

Authors:  Amanda M Enstrom; Charity E Onore; Judy A Van de Water; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2009-08-08       Impact factor: 7.217

2.  Hepatocyte Growth Factor Suppresses Inflammation and Promotes Epithelium Repair in Corneal Injury.

Authors:  Masahiro Omoto; Kunal Suri; Afsaneh Amouzegar; Mingshun Li; Kishore R Katikireddy; Sharad K Mittal; Sunil K Chauhan
Journal:  Mol Ther       Date:  2017-05-11       Impact factor: 11.454

3.  Hepatocyte Growth Factor-c-MET Signaling Mediates the Development of Nonsensory Structures of the Mammalian Cochlea and Hearing.

Authors:  Shumei Shibata; Toru Miwa; Hsiao-Huei Wu; Pat Levitt; Takahiro Ohyama
Journal:  J Neurosci       Date:  2016-08-03       Impact factor: 6.167

4.  Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin's lymphoma.

Authors:  Chuanhui Xu; Wouter Plattel; Anke van den Berg; Nele Rüther; Xin Huang; Miao Wang; Debora de Jong; Hans Vos; Gustaaf van Imhoff; Andreas Viardot; Peter Möller; Sibrand Poppema; Arjan Diepstra; Lydia Visser
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

5.  Decreased Serum Hepatocyte Growth Factor (HGF) in Autistic Children with Severe Gastrointestinal Disease.

Authors:  A J Russo; A Krigsman; B Jepson; Andrew Wakefield
Journal:  Biomark Insights       Date:  2009-11-27

6.  Platelet-derived high-mobility group box 1 promotes recruitment and suppresses apoptosis of monocytes.

Authors:  Sebastian Vogel; Dominik Rath; Oliver Borst; Andreas Mack; Patricia Loughran; Michael T Lotze; Matthew D Neal; Timothy R Billiar; Meinrad Gawaz
Journal:  Biochem Biophys Res Commun       Date:  2016-07-20       Impact factor: 3.575

Review 7.  MET receptor tyrosine kinase as an autism genetic risk factor.

Authors:  Yun Peng; Matthew Huentelman; Christopher Smith; Shenfeng Qiu
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

8.  Association of hepatocyte-derived growth factor receptor/caudal type homeobox 2 co-expression with mucosal regeneration in active ulcerative colitis.

Authors:  Ferenc Sipos; Miklós Constantinovits; Gábor Valcz; Zsolt Tulassay; Györgyi Műzes
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

Review 9.  Control of cortical synapse development and plasticity by MET receptor tyrosine kinase, a genetic risk factor for autism.

Authors:  Xiaokuang Ma; Shenfeng Qiu
Journal:  J Neurosci Res       Date:  2019-11-19       Impact factor: 4.164

Review 10.  Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma.

Authors:  V Finisguerra; H Prenen; M Mazzone
Journal:  Oncogene       Date:  2016-03-21       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.